IRIS
SPINA, Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.252
NA - Nord America 14.411
AS - Asia 8.913
SA - Sud America 3.190
AF - Africa 259
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 12
Totale 44.062
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.137
RU - Federazione Russa 8.319
SG - Singapore 3.875
BR - Brasile 2.783
CN - Cina 2.391
IE - Irlanda 2.106
SE - Svezia 1.704
IT - Italia 1.303
HK - Hong Kong 996
DE - Germania 909
UA - Ucraina 907
FR - Francia 536
VN - Vietnam 512
FI - Finlandia 457
GB - Regno Unito 389
IN - India 343
PL - Polonia 214
AR - Argentina 147
CA - Canada 120
BD - Bangladesh 105
MX - Messico 101
TR - Turchia 91
IQ - Iraq 86
NL - Olanda 82
ZA - Sudafrica 72
EC - Ecuador 66
ID - Indonesia 64
BE - Belgio 60
ES - Italia 52
JP - Giappone 52
PK - Pakistan 51
UZ - Uzbekistan 51
CO - Colombia 49
MA - Marocco 48
AT - Austria 42
CL - Cile 42
VE - Venezuela 42
EE - Estonia 32
PH - Filippine 27
SA - Arabia Saudita 26
AE - Emirati Arabi Uniti 25
DZ - Algeria 25
KE - Kenya 23
AZ - Azerbaigian 22
EG - Egitto 22
TN - Tunisia 22
UY - Uruguay 21
CI - Costa d'Avorio 19
JO - Giordania 19
KZ - Kazakistan 18
NP - Nepal 18
AU - Australia 17
LT - Lituania 17
OM - Oman 17
AL - Albania 16
PY - Paraguay 16
JM - Giamaica 15
CZ - Repubblica Ceca 14
IL - Israele 14
PE - Perù 14
BG - Bulgaria 12
CH - Svizzera 12
LB - Libano 11
MY - Malesia 11
GR - Grecia 10
IR - Iran 10
KG - Kirghizistan 9
RS - Serbia 9
TH - Thailandia 9
AM - Armenia 8
BO - Bolivia 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
PS - Palestinian Territory 8
RO - Romania 8
SN - Senegal 8
KR - Corea 7
LV - Lettonia 7
EU - Europa 6
GE - Georgia 6
PA - Panama 6
TW - Taiwan 6
ET - Etiopia 5
HN - Honduras 5
HR - Croazia 5
NI - Nicaragua 5
BN - Brunei Darussalam 4
KH - Cambogia 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
AO - Angola 3
BY - Bielorussia 3
DK - Danimarca 3
HU - Ungheria 3
LK - Sri Lanka 3
MT - Malta 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 44.016
Salva come PNG Salva come JPEG
Città #
Moscow 2.654
Singapore 2.123
Dublin 2.093
Ashburn 1.885
Jacksonville 1.751
Dallas 1.703
Chandler 1.522
Hong Kong 992
Beijing 888
Nyköping 751
Princeton 400
San Jose 400
The Dalles 396
Cambridge 361
Dearborn 358
Lauterbourg 348
Los Angeles 312
Des Moines 286
Medford 247
Messina 231
Boardman 225
São Paulo 210
New York 196
Ann Arbor 194
Warsaw 194
Buffalo 192
Ho Chi Minh City 165
Munich 137
Hyderabad 136
Tianjin 124
Wilmington 124
Hanoi 105
Guangzhou 97
Houston 96
Redondo Beach 94
Lancaster 93
Rio de Janeiro 87
Milan 86
Woodbridge 77
Jinan 75
Seattle 73
Rome 71
Frankfurt am Main 69
Orem 69
Santa Clara 69
Belo Horizonte 68
Turku 68
Shenyang 65
San Mateo 64
Bremen 63
Brussels 57
Brasília 53
Nanjing 49
Pune 47
Curitiba 46
Tokyo 46
Tashkent 44
Montreal 43
Chennai 41
Catania 40
Baghdad 37
Hangzhou 36
Johannesburg 35
Hebei 34
Porto Alegre 34
Campinas 33
London 33
Council Bluffs 32
Haikou 32
Helsinki 32
Denver 31
Nuremberg 31
Zhengzhou 31
Shenzhen 30
Norwalk 29
Mexico City 27
Stockholm 27
Taizhou 27
Boston 26
Brooklyn 26
Ningbo 26
Atlanta 25
Guarulhos 25
Haiphong 25
Mumbai 25
Recife 25
San Francisco 25
Shanghai 25
Vienna 25
Amsterdam 24
Dhaka 24
Manchester 24
Washington 24
Chicago 23
Salvador 23
Baku 22
Changsha 22
Contagem 22
Guayaquil 22
Poplar 22
Totale 24.654
Salva come PNG Salva come JPEG
Nome #
Efficacia di un trattamento aggiuntivo con olanzapina nel disturbo ossessivo-compulsivo resistente agli SSRI 431
Cutis verticis gyrata primitiva o pachidermia verticis gyrata: contributo clinico-istologico 336
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study 280
Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. 261
A molecular pathway analysis informs the genetic background at risk for schizophrenia. 244
6-Mer Hyaluronan Oligosaccharides ModulateNeuroinflammation and a-Synuclein Expression inNeuron-Like SH-SY5Y Cells 231
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 223
Acute Cerebellar Ataxia Following Meningococcal Group C Conjugate Vaccination 221
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 216
Confronto Teofillina-Doxofillina nella risoluzione del broncospasmo 212
Aripiprazolo in bambini con ADHD in comorbidità con Disturbo da Tic 210
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database 197
"Valproic acid-amitriptyline interaction in man 197
Augmentation con Lamotrigina in pazienti con schizofrenia resistente in trattamento con Clozapina 196
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 193
6-MERS HYALURONAN OLIGOSACCHARIDES STIMULATE INFLAMMATORY RESPONSE IN NEURONAL-LIKE DIFFERENTIATED SH-SY5Y NEUROBLASTOMA CELLS 192
ANTITHETIC ACTION OF HYALURONAN 6-MER IN UNDIFFERENTIATED AND DIFFERENTIATED SH-SY5Y CELLS 187
A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone. 186
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder 185
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 185
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder 185
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 185
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. 184
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 183
Antidepressant use in the elderly: The role of pharmacodynamics and pharmacokinetics in drug safety 183
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 183
Antidepressant effect of hypericum perforatum extract on behaviour and neurogenesis in chronic corticosterone-treated mice. 182
Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity 179
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 179
ABCB1 polymorphisms influence steady state plasma levels of 9-hydroxyrisperidone and risperidone active moiety. 177
Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients 175
Generic Olanzapine Substitution in Patients with Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching 175
ECG parameters in children and adolescents treated with aripiprazole and risperidone 174
Serenoa repens as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report 174
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care 172
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 172
Aripiprazole enhances the antidepressant effect of fluoxetine in mice. 171
Augmentation of clozapine with agomelatine in partial-responder schizophrenia: A 16-week, open-label, uncontrolled pilot study 170
Effects of aripiprazole and risperidone on ventricular repolarization in children and adolescent. 168
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 167
PATTERN PRESCRITTIVO DI FARMACI ANTIEPILETTICI NELL'ANZIANO: STUDIO DI POPOLAZIONE IN UN'AREA DEL SUD ITALIA NEGLI ANNI 2004-2007 166
A double-blind comparative study of bromperidol versus halperidol in schizophrenic patients 166
Real world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study from Southern Italy in the years 2010-2014 166
Aripiprazole enhances the antidepressat effect of fluoxetine in mice. 165
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 165
Clinically Relevant Drug Interactions Between Statins and Antidepressants 164
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 163
Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. XVII Congresso Nazionale della Società Italiana di Neuropsicofarmacologia, Cagliari 22-25 Settembre 2010, p. 47. 163
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 162
Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs. 162
AN ENDOCRINOLOGIC STUDY OF PATIENTS WITH PRIMARY-CUTIS-VERTICIS GYRATA 161
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. 159
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 159
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 158
A pharmacokinetic-pharmacodynamic method for predicting warfarin maintenance dose: preliminary results 158
Efficacia e tollerabilità della quetiapina vs. clozapina in pazienti anziani parkinsoniani con psicosi dopaminergica. 158
No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population 157
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 157
Effetto di un trattamento con risperidone o olanzapina sui livelli serici di prolattina in bambini e adolescenti con patologie psichiatriche. 156
Acute cerebellar ataxia following meningococcal group C conjugate vaccination 156
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 156
“Newer and older antiepileptic drug in southern Italy: a population based study during the years 2003-2005” 154
Risperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implications 154
5-HT2A and 5-HT2C receptor polymorphisms and psychotic symptoms in Alzheimer's disease 154
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. 151
Drug-induced urinary retention: an analysis of a national spontaneous adverse drug reaction reporting database 151
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 150
Uso dell’Aripiprazolo in bambini con Multiple-complex Developmental Disorder (McDD). 149
Tossicità cardiovascolare degli antipsicotici atipici in età evolutiva 149
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population 148
Age-related changes in pharmacodynamics: focus on drug acting on cetral nervous and cardiovascular systems 148
Early atypical injection-site reactions to COVID-19 vaccine: a case series 147
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with Attention Deficit Hyperactivity Disorder 147
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 147
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. 146
“Augmentation con Duloxetina vs. placebo in un campione di schizofrenici partial responders in trattamento stabilizzato con antipsicotici atipici”. 146
Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies 145
PARKINSONISMO ED INIBITORI SELETTIVI DEL REUPTAKE DELLA SEROTONINA 144
Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. 144
Prescribing pattern of antiepileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-2007 143
Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olazapine and risperidone I patients with psychotic disorders 143
Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders 142
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years 142
Effectiveness and safety profile of dupilumab in chronic Rhinosinusitis with nasal polyps: real-life data in tertiary care 141
ADJUNCTIVE FLUOXETINE IN THE TREATMENT OF NEGATIVE SYMPTOMS IN CHRONIC-SCHIZOPHRENIC PATIENTS 141
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 141
Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics. 140
Impiego clinico del Risperidone in età evolutiva: variazioni farmacocinetiche e cliniche 139
Neuropsychiatric reactions to drugs: an analysis of spontaneous reports from general practitioners in Italy. 139
Effect of valpromide on the pharmacokinetics of Carbamazepine-10,11-epoxide 139
Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia: A Double-Blind, Placebo-Controlled Study. 139
Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011 138
Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence 138
Impiego del Risperidone nel disturbo autistico: valutazioni farmacocinetiche e cliniche 137
Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model. 136
Effect of valproate on plasma concentrations of olanzapine in patients with psychotic disorders , July, 2009, MP 110.. 135
Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study 135
“Effect of valproic acid on plasma concentrations of olanzapine in patients with psychiatric disorders” 134
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis 134
USE AND TOLERABILITY OF NEWER ANTIPSYCHOTICS AND ANTIDEPRESSANTS: A CHART REVIEW IN A PAEDIATRIC SETTING. 133
Totale 17.081
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.058
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021611 0 0 0 0 0 0 0 0 0 338 133 140
2021/20222.228 27 225 31 78 50 23 133 114 83 446 293 725
2022/20235.906 509 412 218 480 521 543 52 347 2.554 28 176 66
2023/20241.672 121 246 109 169 168 338 70 102 26 164 19 140
2024/20257.254 96 95 156 401 381 220 137 1.647 1.938 446 582 1.155
2025/202619.951 911 1.411 1.804 1.471 1.592 4.527 2.411 2.477 2.577 770 0 0
Totale 44.486